{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/90245281"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "In neuroscience, we are addressing conditions such as Alzheimer's disease, Parkinson's, schizophrenia, pain and MS. Daclizumab, our next generation biologic for MS is in Phase III development." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "seekingalpha.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/318770500"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/90245281" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/193864746"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/90245281"] } } }
